The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.

In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.

Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.

本期刊旨在为对先进药物和基因递送系统及其在人类和兽医学中的应用进行批判性分析提供一个论坛。本期刊涵盖范围广泛，涵盖有效药物和基因递送的关键问题，从给药到位点递送。

一般来说，本期刊以专题期刊的形式发表评论文章。每个专题期刊都对先进药物和基因递送系统的设计和开发及其在实验和临床治疗中的应用的当前和新兴研究进行全面和批判性的审查。其目标是说明多学科方法在现代药物递送中的关键作用，包括将合理的生物学和物理化学原理应用于药物递送系统的工程设计以满足当前的治疗需求。重要的是，ADDR 的编辑团队要求作者有效地浏览大量文献，挑选出重要的贡献并解释其重要性，对该领域面临的挑战进行前瞻性的识别，并撰写结论部分，其中包含专家建议以解决问题。

文章回顾了特定主题的当前状态，同样强调识别成功药物和基因递送的主要概念和技术挑战，评估当前概念和技术方法的成功和不足，并讨论其可能的解决方案。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映药学-医学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为15.2，平均审稿速度为 一般,3-8周 约15.1周，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。